Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh

Ridwanur Rahman; Vishal Goyal; Rashidul Haque; Kazi Jamil; Abul Faiz; Rasheda Samad; Sally Ellis; Manica Balasegaram; Margriet den Boer; Suman Rijal; Nathalie Strub-Wourgaft; Fabiana Alves; Jorge Alvar; Bhawna Sharma

doi:10.1371/journal.pntd.0005635

Loading metrics

Open Access

Peer-reviewed

Research Article

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh

Ridwanur Rahman ,

Contributed equally to this work with: Ridwanur Rahman, Vishal Goyal

Affiliation Shaheed Suhrawardy Medical College (ShSMC), University of Dhaka, Dhaka, Bangladesh
⨯
Vishal Goyal ,

Contributed equally to this work with: Ridwanur Rahman, Vishal Goyal

* E-mail: vgoyal@dndi.org

Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

http://orcid.org/0000-0003-3564-129X

⨯
Rashidul Haque,

Affiliation International Centre for Diarrhoeal Disease Research (ICDDR,B), Dhaka, Bangladesh
⨯
Kazi Jamil,

Affiliation Kuwait institute for Scientific Research, Environment and Life Sciences Research centre, Food and Nutrition Program formerly ICDDR,B, Dhaka, Bangladesh
⨯
Abul Faiz,

Affiliation Dev Care Foundation, Dhaka, Bangladesh and Retired Ministry of Health, Government official Dhaka, Bangladesh
⨯
Rasheda Samad,

Affiliation Chittagong Medical College, Chittagong, Bangladesh
⨯
Sally Ellis,

Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯
Manica Balasegaram,

Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯
Margriet den Boer,

Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯
Suman Rijal,

Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯
Nathalie Strub-Wourgaft,

Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯
Fabiana Alves,

Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯
Jorge Alvar,

Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯
Bhawna Sharma

Affiliation Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
⨯

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh

Ridwanur Rahman,
Vishal Goyal,
Rashidul Haque,
Kazi Jamil,
Abul Faiz,
Rasheda Samad,
Sally Ellis,
Manica Balasegaram,
Margriet den Boer,
Suman Rijal

Published: May 30, 2017
https://doi.org/10.1371/journal.pntd.0005635

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Bangladesh
Is the Subject Area "Bangladesh" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Leishmaniasis
Is the Subject Area "Leishmaniasis" applicable to this article?

Thanks for your feedback.
India
Is the Subject Area "India" applicable to this article?

Thanks for your feedback.
Vomiting
Is the Subject Area "Vomiting" applicable to this article?

Thanks for your feedback.
Phase III clinical investigation
Is the Subject Area "Phase III clinical investigation" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.